Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

Vera J. Suman, Lili Du, Tanya Hoskin, Meenakshi Anurag, Cynthia Ma, Isabelle Bedrosian, Kelly K. Hunt, Matthew J. Ellis, W. Fraser Symmans

Clin Cancer Res OF1–OF9.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0068

Published: 27 June 2022

View article

Includes: Supplementary data

Journal Articles

Interpreting the Complex Landscape of Immune–Tumor Interface

W. Fraser Symmans

Clin Cancer Res (2021) 27 (20): 5446–5448.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2208

Published: 15 October 2021

View article

Journal Articles

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Kelly K. Hunt, Cansu Karakas, Min Jin Ha, Anna Biernacka, Min Yi, Aysegul A. Sahin, Opoku Adjapong, Gabriel N. Hortobagyi, Melissa L. Bondy, Patricia A. Thompson, Kwok Leung Cheung, Ian O. Ellis, Sarah Bacus, W. Fraser Symmans, Kim-Anh Do, Khandan Keyomarsi

Clin Cancer Res (2017) 23 (12): 2991–3002.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-2217

Published: 14 June 2017

View article

Includes: Supplementary data

Journal Articles

Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer

Christos Hatzis, W. Fraser Symmans, Ya Zhang, Rebekah E. Gould, Stacy L. Moulder, Kelly K. Hunt, Maysa Abu-Khalaf, Erin W. Hofstatter, Donald Lannin, Anees B. Chagpar, Lajos Pusztai

Clin Cancer Res (2016) 22 (1): 26–33.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-3304

Published: 03 January 2016

View article

Includes: Supplementary data

Journal Articles

CCR 20^th Anniversary Commentary: Divide and Conquer—Breast Cancer Subtypes and Response to Therapy

Lajos Pusztai, Roman Rouzier, W. Fraser Symmans

Clin Cancer Res (2015) 21 (16): 3575–3577.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-3121

Published: 13 August 2015

View article

Journal Articles

Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

Lajos Pusztai, Stacy Moulder, Mehmet Altan, Danielle Kwiatkowski, Vicente Valero, Naoto T. Ueno, Francisco J. Esteva, Rony Avritscher, Yuan Qi, Lewis Strauss, Gabriel N. Hortobagyi, Christos Hatzis, W. Fraser Symmans

Clin Cancer Res (2014) 20 (20): 5265–5271.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-0800

Published: 14 October 2014

View article

Includes: Supplementary data

Journal Articles

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Hiroko Masuda, Keith A. Baggerly, Ying Wang, Ya Zhang, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Vicente Valero, Brian D. Lehmann, Jennifer A. Pietenpol, Gabriel N. Hortobagyi, W. Fraser Symmans, Naoto T. Ueno

Clin Cancer Res (2013) 19 (19): 5533–5540.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-0799

Published: 01 October 2013

View article

Includes: Supplementary data

Journal Articles

Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Ke-Da Yu, Rui Zhu, Ming Zhan, Angel A. Rodriguez, Wei Yang, Stephen Wong, Andreas Makris, Brian D. Lehmann, Xi Chen, Ingrid Mayer, Jennifer A. Pietenpol, Zhi-Ming Shao, W. Fraser Symmans, Jenny C. Chang

Clin Cancer Res (2013) 19 (10): 2723–2733.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-2986

Published: 12 May 2013

View article

Includes: Supplementary data

Journal Articles

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

Ana M. Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, Huiqin Chen, Kim-Anh Do, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam, W. Fraser Symmans, Lajos Pusztai

Clin Cancer Res (2012) 18 (4): 1109–1119.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-2762

Published: 14 February 2012

View article

Includes: Supplementary data

Journal Articles

Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Charles Coutant, Roman Rouzier, Yuan Qi, Jacqueline Lehmann-Che, Giampaolo Bianchini, Takayuki Iwamoto, Gabriel N. Hortobagyi, W. Fraser Symmans, Serge Uzan, Fabrice Andre, Hugues de Thé, Lajos Pusztai

Clin Cancer Res (2011) 17 (8): 2591–2601.

DOI: https://doi.org/10.1158/1078-0432.CCR-10-1045

Published: 14 April 2011

View article

Includes: Supplementary data

Journal Articles

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Adel Tabchy, Vicente Valero, Tatiana Vidaurre, Ana Lluch, Henry Gomez, Miguel Martin, Yuan Qi, Luis Javier Barajas-Figueroa, Eduardo Souchon, Charles Coutant, Franco D. Doimi, Nuhad K. Ibrahim, Yun Gong, Gabriel N. Hortobagyi, Kenneth R. Hess, W. Fraser Symmans, Lajos Pusztai

Clin Cancer Res (2010) 16 (21): 5351–5361.

DOI: https://doi.org/10.1158/1078-0432.CCR-10-1265

Published: 31 October 2010

View article

Includes: Supplementary data

Journal Articles

Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

Jae K. Lee, Charles Coutant, Young-Chul Kim, Yuan Qi, Dan Theodorescu, W. Fraser Symmans, Keith Baggerly, Roman Rouzier, Lajos Pusztai

Clin Cancer Res (2010) 16 (2): 711–718.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-2247

Published: 14 January 2010

View article

Includes: Supplementary data

Journal Articles

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Fabrice Andre, Bastien Job, Philippe Dessen, Attila Tordai, Stefan Michiels, Cornelia Liedtke, Catherine Richon, Kai Yan, Bailang Wang, Gilles Vassal, Suzette Delaloge, Gabriel N. Hortobagyi, W. Fraser Symmans, Vladimir Lazar, Lajos Pusztai

Clin Cancer Res (2009) 15 (2): 441–451.

DOI: https://doi.org/10.1158/1078-0432.CCR-08-1791

Published: 15 January 2009

View article

Includes: Supplementary data

Journal Articles

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

Stacy L. Moulder, W. Fraser Symmans, Daniel J. Booser, Timothy L. Madden, Cindy Lipsanen, Linda Yuan, Abenaa M. Brewster, Massimo Cristofanilli, Kelly K. Hunt, Thomas A. Buchholz, James Zwiebel, Vicente Valero, Gabriel N. Hortobagyi, Francisco J. Esteva

Clin Cancer Res (2008) 14 (23): 7909–7916.

DOI: https://doi.org/10.1158/1078-0432.CCR-08-1104

Published: 01 December 2008

View article

Journal Articles

Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer

Florentia Peintinger, Keith Anderson, Chafika Mazouni, Henry M. Kuerer, Christos Hatzis, Feng Lin, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai

Clin Cancer Res (2007) 13 (14): 4078–4082.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-2600

Published: 18 July 2007

View article

Journal Articles

Standardizing Slide-Based Assays in Breast Cancer: Hormone Receptors, HER2, and Sentinel Lymph Nodes

Jeffrey S. Ross, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobagyi

Clin Cancer Res (2007) 13 (10): 2831–2835.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-2522

Published: 15 May 2007

View article

Journal Articles

Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer

Fabrice Andre, Christos Hatzis, Keith Anderson, Christos Sotiriou, Chafika Mazouni, Jaime Mejia, Bailiang Wang, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai

Clin Cancer Res (2007) 13 (7): 2061–2067.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-2078

Published: 02 April 2007

View article

Includes: Supplementary data

Journal Articles

Genomic Testing for Sensitivity of Breast Cancer to Hormonal Therapy

W. Fraser Symmans

Clin Cancer Res (2006) 12 (7): 1954–1955.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-0289

Published: 11 April 2006

View article

Journal Articles

Reproducibility of Gene Expression Signature–Based Predictions in Replicate Experiments

Keith Anderson, Kenneth R. Hess, Mini Kapoor, Stephen Tirrell, Jean Courtemanche, Bailiang Wang, Yun Wu, Yun Gong, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai

Clin Cancer Res (2006) 12 (6): 1721–1727.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-1539

Published: 21 March 2006

View article

Includes: Supplementary data

Journal Articles

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R. Hess, James Stec, Mark Ayers, Peter Wagner, Paolo Morandi, Chang Fan, Islam Rabiul, Jeffrey S. Ross, Gabriel N. Hortobagyi, Lajos Pusztai

Clin Cancer Res (2005) 11 (16): 5678–5685.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-2421

Published: 22 August 2005

View article

Includes: Supplementary data

NARROW

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

Interpreting the Complex Landscape of Immune–Tumor Interface

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer

CCR 20^th Anniversary Commentary: Divide and Conquer—Breast Cancer Subtypes and Response to Therapy

Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer

Standardizing Slide-Based Assays in Breast Cancer: Hormone Receptors, HER2, and Sentinel Lymph Nodes

Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer

Genomic Testing for Sensitivity of Breast Cancer to Hormonal Therapy

Reproducibility of Gene Expression Signature–Based Predictions in Replicate Experiments

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only